猪血凝性脑脊髓炎免疫层析检测试纸及其灭活疫苗的研制
|
摘要
猪血凝性脑脊髓炎是由血凝性脑脊髓炎病毒(hemagglutinating encephalomyelitis virus, HEV)引起仔猪的一种急性、接触性传染病。HEV属于冠状病毒属成员,其主要侵害1-3周龄的仔猪,临床上以仔猪呕吐、衰竭和明显的神经症状为主要特征,死亡率达20-100%。1962年,该病原从加拿大患脑脊髓炎的哺乳仔猪体内首次分离获得。1972年,比利时人Pensaert MB从暴发“呕吐和衰竭”症状,而未出现“脑脊髓炎”神经症状的死亡猪扁桃体中分离获得HEV-VW572毒株。以后,世界上许多国家均有该病的报道,尤其以日本、加拿大等国家危害比较严重。血清学调查显示,猪感染HEV非常普遍,且呈世界性分布,大部分被感染的猪处于亚临床状态,一旦发病,将给养猪业造成巨大的经济损失。目前,常规的HEV检测技术主要有病毒分离鉴定、RT-PCR、巢式PCR、血凝/血凝抑制试验(HA/HI)、血清中和试验(VN)等方法。但这些检测方法大多需要专业的技术人员、特定的操作环境以及一些特殊的仪器设备,不适合基层现场检验工作的需要,满足不了该病暴发流行时紧急应对的要求,所以在一定程度上限制了其在兽医临床诊断中的应用。因此,开发一种操作简单、使用方便快捷的HEV检测方法对于基层兽医工作者十分必要。
近年来,随着单克隆抗体(McAb)技术的发展与成熟,其在分子生物学、免疫学、生物化学、遗传学等许多领域得到了广泛的应用,许多疾病诊断和鉴别诊断方法的建立都与McAb有关。本研究应用蔗糖密度梯度离心法纯化HEV,免疫Balb/c小鼠,取小鼠脾细胞与SP2/0骨髓瘤细胞进行融合,用间接ELISA筛选杂交瘤细胞,获得4株稳定分泌抗HEV的单克隆抗体,分别命名为2H2、2A1、1E2、4D4。经鉴定,4株McAb的ELISA效价在1：12800～1：51200之间；亚类鉴定证实,除1E2为IgG2a外其余3株单抗均为IgGl;Western blot分析表明,2H2、1E2和4D4能识别HEV的血凝素-酯酶蛋白(HE),2Al可识别纤突蛋白(S)；经间接ELISA及间接免疫荧光鉴定,4株单抗均能与HEV结合,其特异性良好；用单抗2A1和2H2建立检测HEV的双抗体夹心ELISA方法,最低可检测3.75μg/mL的病毒,且与猪传染性胃肠炎病毒(TGEV)、猪流行性腹泻病毒(PEDV)、猪伪狂犬病毒(PRV)、猪瘟病毒(HCV)及牛冠状病毒(BCV)等无交叉反应,说明该方法可用于HEV的检测。
胶体金免疫层析技术(Gold Immunochromtographic assay, GICA)是将免疫胶体金技术(Immunogold labeling technique)与层析法结合,以胶体金作为标记物,应用于抗原与抗体之间反应的一种新型检测技术。将McAb与GICA结合制备的胶体金检测试纸条具有操作简单快速、检测结果清楚易于判断、特异性强、敏感性高、无需仪器设备或只需简单的仪器等优点,因此非常适于发病现场、门诊以及实验条件不具备的场所使用,在医学和动物医学检疫、检验等方面已被广泛应用。本实验在成功制备HEV单克隆抗体的基础上,结合胶体金免疫层析技术研制检测HEV的胶体金免疫层析试纸条。首先应用柠檬酸三钠还原法制备胶体金溶液,经电镜观察胶体金颗粒大小在30nm左右；通过梯度法确定McAb与胶体金结合的最佳pH值为8.5,最佳结合浓度为37μg/mL;将制备好的金标单抗包被玻璃纤维膜,另一株McAb及羊抗小鼠IgG分别喷点硝酸纤维膜(NC膜)检测线和质控线,组装试纸条。用该试纸条检测不同浓度的HEV,结果最低可检测30μg/mL的病毒；特异性实验结果表明该试纸条在检测TGEV.PEDV.PRV、HCV.BCV及MHV等病毒时不发生交叉反应；分别用试纸条.RT-PCR及ELISA方法对50份临床样本做平行检测,结果试纸条与RT-PCR和ELISA的符合率为98%,其Kappa值为0.956,说明本实验研制的试纸条可用于临床HEV的检测。
应用胶体金免疫层析技术研制检测HEV血清抗体的胶体金免疫层析试纸条,首先将兔抗猪IgG标记胶体金包被玻璃纤维膜,然后用喷点仪将纯化的HEV和羊抗兔IgG分别喷点于NC膜的检测线和质控线,组装成试纸条。用该试纸条分别检测HEV、TGEV、PEDV、PRV、HCV及BCV的阳性血清并用其检测不同HI抗体效价的HEV阳性血清,结果试纸条仅对HEV阳性血清检测时,在检测线及质控线出现清晰的红色条带,且最低可检测HI效价为21的HEV阳性血清,说明试纸条具有很好的特异性和敏感性；用同一批次和不同批次的试纸条检测HEV阳性血清,结果试纸条批内重复及批间重复差异不大,变异系数为0.82%,证明试纸条重复性较好；保存期试验证明该试纸条4℃保存12个月,其特异性和敏感性均未发生变化,说明试纸条具有很好的稳定性；分别用试纸条、ELISA及HI试验对50份临床血清样本进行检测,评估试纸条与二者的相关性。结果试纸条与ELISA的符合率为98%, Kappa值为0.953；与HI试验的符合率为96%,Kappa值为0.911,说明试纸条可代替ELISA和HI试验用于临床血清样本检测。应用本实验室研制的试纸条对吉林省及辽宁省部分地区进行HEV的血清抗体调查,结果672份血清样本中,有334份呈阳性,总阳性率为49.7%,提示被检测地区的猪群中普遍存在HEV感染。
目前,HEV的暴发呈上升趋势,且未见有关预防或治疗HEV的特效药物或疫苗的研究报道,仅在国外部分国家应用“亚感染”进行预防,即在母猪临产前一个月与病猪接触或喷雾或肌肉注射培养的弱毒,使母猪获得免疫,进而通过初乳中的抗体保护后代仔猪,使其不表现临床症状,而这些猪大多呈亚临床感染,且此种免疫方法存在着散毒的危险。因此,研制高效安全的疫苗对HEV的防治有重要的现实意义。本试验选用HEV-67N标准毒株作为疫苗研制的候选毒株,通过优化体外培养条件,确定HEV-67N在PK-15细胞上培养传代,并建立PK-15细胞的原始种子细胞库(123～126代细胞)、基础种子细胞库(127～136代细胞)和工作种子细胞库(137～141代细胞)；同时分别建立HEV-67N原始种子病毒库、基础种子病毒库和工作种子病毒库；随机抽取细胞库及病毒库中的细胞和病毒,通过镜下观察、无菌检验、支原体检测及核酸分析等检测均符合“兽用生物制品质量标准”；然后在筛选出优良佐剂的基础上,取工作种子病毒库的病毒液,经4%o甲醛灭活后,按《中华人民共和国兽用生物制品质量标准》规定,将氢氧化铝胶佐剂和灭活的病毒按1∶9比例混匀,制备HEV细胞培养灭活疫苗。随机抽取实验室制备的疫苗以不同剂量接种Balb/c小鼠和怀孕母猪,结果该疫苗除了可以诱导良好的特异性免疫应答外,不产生任何临床副作用,说明本疫苗对小鼠和怀孕母猪是安全有效的；对注射疫苗后产生不同抗体效价的Balb/c小鼠进行脑内攻毒,结果当小鼠HI抗体效价≥25时,其保护率可达80%以上,且HI抗体效价滴度与免疫攻毒试验间存在良好的平行关系,可代替常规的攻毒保护率试验；将HEV灭活疫苗免疫Balb/c小鼠,结果小鼠经3次免疫后,HI抗体效价最高达29,进而通过血清亚类鉴定、淋巴细胞增殖实验、细胞因子检测等方法证实,该疫苗可刺激小鼠产生特异性的体液免疫应答,且以Th2型免疫应答为主；最后对疫苗的保存期进行评定,疫苗在2～8℃和室温(13℃～28℃)分别保存至12个月和4个月时,其物理性状及免疫效力未见变化,这与灭活疫苗稳定、便于保存运输的特点基本一致。由此可见,本实验制备的HEV灭活疫苗可安全有效的刺激机体产生特异性免疫应答,仔猪可通过经疫苗免疫的怀孕母猪产生HEV抗体,从而达到预防该病的目的,该疫苗的研制对HEV的防治有重要的现实意义。
Porcine hemagglutinating encephalomyelitis is an acute, highly contagious disease in piglets caused by the hemagglutinating encephalomyelitis virus (HEV). HEV belongs to the family of Coronaviridae, which included encephalomyelitis and Vomiting and wasting disease clinically type and mainly infects 1-to 3-week-old piglet causes vomiting, exhaustion, and neurological signs. The mortality rate varies from 20% to 100%. In 1962. the pathogen was isolated for the first time from suckling piglets suffering from encephalomyelitis in Canada. In 1972, the PHEV-VW572 strain was isolated from the tonsils of pigs that exhibited only vomiting and exhaustion symptoms, but no neurological signs. Serological surveys revealed that HEV infections in pigs are very common worldwide, most of the infected pigs in a sub-clinical state, once the disease, will cause huge economic losses. At present, various laboratory methods are available for the detection and surveillance of HEV. including virus isolation and identification, RT-PCR, nested PCR, hemagglutination and hemagglutination inhibition (HA and HI,respectively) tests, the enzyme-linked immunosorbent assay (ELISA). and the virus neutralization (VN) test. However, these detection methods are laborious, time-consuming, and require laboratory operations or special equipment, which makes these methods unsuitable for on-site inspection. As such, the current methods would not be useful for managing an outbreak of the disease. Therefore, it was necessary to develop a sensitive, specific, and easily performed detection method for on-site detection of HEV or HEV antibodies in order to increase the surveillance of HEV infections.
In recent years, with the monoclonal antibody (McAb) technology development and maturation, molecular biology, immunology, bacteriology, virology, biochemistry, genetics and many other fields have been widely used. Many diseases, diagnosis and differential diagnosis were established with the McAb.In this study, Balb/c mice were immunized subcutaneously with HEV purified by sucrose density gradient centrifugation, their splenic mononuclear cells were isolated and fused with murine myeloma cells (SP2/0). The hybridomas were generated through the selection of HAT medium and screened using Enzyme-linked immunosorbent assay (ELISA) and access to four single-secreting anti-HEV McAb, named 2H2,2A1,1E2,4D4. Identified,4 McAb ELISA titers between 1:12800 and 1:51200; subgroup identification,1E2 for the IgG2a,2H2、2A1 and 4D4 for the IgG1;Western blot analysis showed that 2H2,1E2 and 4D4 to recognize HEV hemagglutinin-esterase protein (HE),2A1 may recognize spike protein (S). Development of the sandwich ELISA with McAb 2A1 and 2H2 for detection HEV, the minimum could be detected 3.75μg/mL for HEV, and infection with the transmissible gastro-enteritis virus (TGEV), porcine Epidemic diarrhea (PEDV), porcine pseudorabies virus (PRV), Hogcholera virus (HCV) and bovine coronavirus (BCV) and so no cross reaction, wihich shows that the sandwich ELISA can be used for HEV detection.
Colloidal gold immunochromatographic assay (GICA) is a solid-phase immunoassay developed in the 1980s that combines the techniques of colloidal gold labeling, chromatographic analysis, immunodetection and other methods. Because of GICA's convenience and speed as well as its specificity and sensitivity and ability to be used without instruments or with only a simple instrument, it is suitable for clinical diagnosis and drug testing purposes and can be used anywhere.In this study, an immunochromatographic strip with high sensitivity and specificity was successfully developed for the detection of HEV. combining McAb and GICA.The colloidal gold particles were consistent in size and uniformly distributed, with a mean diameter of about 30nm when observed under a transmission electron microscope; monoclonal antibodies by gradient method to determine the best combination of colloidal gold pH 8.5, the best combination of a concentration of 37μg/mL. The colloidal gold-labeled MAb 2H2 solution was dispensed onto glass fiber paper at a speed of 50μl per cm using an XYZ3000 Dispense Workstation, and the MAb 2A1 or the goat anti-mouse antibody was dispensed at the test or the control line on the NC membrane using XYZ-3000; the sample pad, pretreated conjugate pad. NC membrane, and absorbent pads were glued together on a support board and assembled into a test strip.The immunochromatographic strip was capable of specifically detecting HEV with 30μg/mL within 10 min. Storage of the strips at room temperature for 6 months or at 4℃for 12 months did not change their sensitivity or specificity. Using RT-PCR and ELISA as reference test, the excellent agreement (98%; kappa= 0.956) between the results obtained by RT-PCR or ELISA and the immunochromatographic strips. Based on its high specificity, sensitivity, and stability, the immunochromatographic strip would be suitable for on-site detection of HEV for surveillance and epidemiological purposes.
An immunochromatographic strip was developed for the detection of an antibody against HEV. Colloidal gold-labeled rabbit anti-pig immunoglobulin G (IgG) was used as the detection reagent, and the HEV recombinant antigens and goat anti-rabbit IgG were coated on the prototype strip and the control lines, respectively. The immunochromatographic strip was capable of specifically detecting HEV antibodies in serum with a HI titer of 2 within 10 min. Storage of the strips at room temperature for 6 months or at 4℃for 12 months did not change their sensitivity and specificity. Using HI as a reference test, there was a strong agreement between the results obtained by HI and the immunochromatographic strips (kappa=0.911). Additionally, there was a strong agreement between ELISA and immunochromatographic strips (kappa=0.953). When the immunochromatographic strip was used for serological diagnosis of 672 serum samples in the Jilin and Liaoning province in China, the seropositivity ranged from 42.08% in Jinzhou District to 65.33% in Baishan District. Based on the high specificity, sensitivity, and stability of the immunochromatographic strip, it would be suitable for on-site detection of HEV antibodies in order to monitor HEV infections in an animal population.
Currently, there is no effect on the prevention or treatment of HEV drugs or vaccines has been reported, applied only in some countries abroad, "subclinical infection" of prevention, that is, one month before labor in sows contact with sick, spray or intramuscular injection training the attenuated HEV. When the sow immunitied, piglets gain the antibodies through colostrum, but it does not show clinical symptoms, most of these pigs showed a subclinical infection, and this immunological method exist clinical infection hidden danger. Therefore, the development of efficiently and safely vaccine against HEV prevention has important practical significance. In this study, based on HEV-67N strain as a vaccine candidate strains developed by optimizing the in vitro culture conditions to determine the HEV-67N PK-15 cells in culture and passage, using the nutrient medium with 0.4% BSA; establishment of PK-15 cells of the original seed cell banks (123～126 cells), based on the seed cell bank (127～136 cells) and the working seed cell bank (137～141 cells); the same time establish HEV-67N, respectively, the original seed virus database. foundation seed and working seed virus database virus database; random sample of the virus in the cell library and PK-15 cells and HEV-67N by microscopy, sterility test, mycoplasma detection and analysis of nucleic acids which adhere to "quality standards for veterinary biologics." In the adjuvant selected on the basis of quality, taking the virus working seed virus database solution, inactivated by 4‰formaldehyde, By "People's Republic of Veterinary Biological Products Quality Standards " provides, the aluminum hydroxide gel adjuvant and inactivated virus at 1:9 ratio of mixing, preparation HEV cell culture inactivated vaccine. Randomly selected the vaccine which prepared in labs Vaccination to Balb/cmice and pregnant sows, the results show that favourable specific immune response induced by the vaccine. The vaccine is also safe an effective to mice and pregnant sows. There is no adverse reaction happened on mice and sows after injecting the vaccine. On post-vaccination antibody titers have different Balb/c mice brain attack drugs, the protection rate is more than 80% when the mice's HI antibody titers≥2(?).There is satisfactory parallel relationship between HI antibody titers and immune attack drug test. It can replace convetional attack protection rate test. HEV inactivated vaccine inoculated Balb/c mice, HI antibody titers of mice up to 29 after the third immunization. The immune mice could produce specific humoral immune response certificated by serum sub-categories, lymphocyte proliferation, cytokines and other methods. The main of immune response is Th2 type. Finally, the preservation of the vaccines evaluated. The physical properties and immune effect of the vaccine was no change when the vaccine stored at 2-8℃for 12 months and room temperature (13℃-28℃) for 4 months.It basically the same characteristics as inactivated vaccine stability, ease of transportation and conservation. Thus, in this study, the body could produce specific immune response by the prepared HEV vaccine safely and efectively. Piglets generated the antibodies from the immunization of pregnant sows to achieve the purpose of preventing the disease.The vaccine has important practical significance to prevention of HEV
近年来,随着单克隆抗体(McAb)技术的发展与成熟,其在分子生物学、免疫学、生物化学、遗传学等许多领域得到了广泛的应用,许多疾病诊断和鉴别诊断方法的建立都与McAb有关。本研究应用蔗糖密度梯度离心法纯化HEV,免疫Balb/c小鼠,取小鼠脾细胞与SP2/0骨髓瘤细胞进行融合,用间接ELISA筛选杂交瘤细胞,获得4株稳定分泌抗HEV的单克隆抗体,分别命名为2H2、2A1、1E2、4D4。经鉴定,4株McAb的ELISA效价在1：12800～1：51200之间；亚类鉴定证实,除1E2为IgG2a外其余3株单抗均为IgGl;Western blot分析表明,2H2、1E2和4D4能识别HEV的血凝素-酯酶蛋白(HE),2Al可识别纤突蛋白(S)；经间接ELISA及间接免疫荧光鉴定,4株单抗均能与HEV结合,其特异性良好；用单抗2A1和2H2建立检测HEV的双抗体夹心ELISA方法,最低可检测3.75μg/mL的病毒,且与猪传染性胃肠炎病毒(TGEV)、猪流行性腹泻病毒(PEDV)、猪伪狂犬病毒(PRV)、猪瘟病毒(HCV)及牛冠状病毒(BCV)等无交叉反应,说明该方法可用于HEV的检测。
胶体金免疫层析技术(Gold Immunochromtographic assay, GICA)是将免疫胶体金技术(Immunogold labeling technique)与层析法结合,以胶体金作为标记物,应用于抗原与抗体之间反应的一种新型检测技术。将McAb与GICA结合制备的胶体金检测试纸条具有操作简单快速、检测结果清楚易于判断、特异性强、敏感性高、无需仪器设备或只需简单的仪器等优点,因此非常适于发病现场、门诊以及实验条件不具备的场所使用,在医学和动物医学检疫、检验等方面已被广泛应用。本实验在成功制备HEV单克隆抗体的基础上,结合胶体金免疫层析技术研制检测HEV的胶体金免疫层析试纸条。首先应用柠檬酸三钠还原法制备胶体金溶液,经电镜观察胶体金颗粒大小在30nm左右；通过梯度法确定McAb与胶体金结合的最佳pH值为8.5,最佳结合浓度为37μg/mL;将制备好的金标单抗包被玻璃纤维膜,另一株McAb及羊抗小鼠IgG分别喷点硝酸纤维膜(NC膜)检测线和质控线,组装试纸条。用该试纸条检测不同浓度的HEV,结果最低可检测30μg/mL的病毒；特异性实验结果表明该试纸条在检测TGEV.PEDV.PRV、HCV.BCV及MHV等病毒时不发生交叉反应；分别用试纸条.RT-PCR及ELISA方法对50份临床样本做平行检测,结果试纸条与RT-PCR和ELISA的符合率为98%,其Kappa值为0.956,说明本实验研制的试纸条可用于临床HEV的检测。
应用胶体金免疫层析技术研制检测HEV血清抗体的胶体金免疫层析试纸条,首先将兔抗猪IgG标记胶体金包被玻璃纤维膜,然后用喷点仪将纯化的HEV和羊抗兔IgG分别喷点于NC膜的检测线和质控线,组装成试纸条。用该试纸条分别检测HEV、TGEV、PEDV、PRV、HCV及BCV的阳性血清并用其检测不同HI抗体效价的HEV阳性血清,结果试纸条仅对HEV阳性血清检测时,在检测线及质控线出现清晰的红色条带,且最低可检测HI效价为21的HEV阳性血清,说明试纸条具有很好的特异性和敏感性；用同一批次和不同批次的试纸条检测HEV阳性血清,结果试纸条批内重复及批间重复差异不大,变异系数为0.82%,证明试纸条重复性较好；保存期试验证明该试纸条4℃保存12个月,其特异性和敏感性均未发生变化,说明试纸条具有很好的稳定性；分别用试纸条、ELISA及HI试验对50份临床血清样本进行检测,评估试纸条与二者的相关性。结果试纸条与ELISA的符合率为98%, Kappa值为0.953；与HI试验的符合率为96%,Kappa值为0.911,说明试纸条可代替ELISA和HI试验用于临床血清样本检测。应用本实验室研制的试纸条对吉林省及辽宁省部分地区进行HEV的血清抗体调查,结果672份血清样本中,有334份呈阳性,总阳性率为49.7%,提示被检测地区的猪群中普遍存在HEV感染。
目前,HEV的暴发呈上升趋势,且未见有关预防或治疗HEV的特效药物或疫苗的研究报道,仅在国外部分国家应用“亚感染”进行预防,即在母猪临产前一个月与病猪接触或喷雾或肌肉注射培养的弱毒,使母猪获得免疫,进而通过初乳中的抗体保护后代仔猪,使其不表现临床症状,而这些猪大多呈亚临床感染,且此种免疫方法存在着散毒的危险。因此,研制高效安全的疫苗对HEV的防治有重要的现实意义。本试验选用HEV-67N标准毒株作为疫苗研制的候选毒株,通过优化体外培养条件,确定HEV-67N在PK-15细胞上培养传代,并建立PK-15细胞的原始种子细胞库(123～126代细胞)、基础种子细胞库(127～136代细胞)和工作种子细胞库(137～141代细胞)；同时分别建立HEV-67N原始种子病毒库、基础种子病毒库和工作种子病毒库；随机抽取细胞库及病毒库中的细胞和病毒,通过镜下观察、无菌检验、支原体检测及核酸分析等检测均符合“兽用生物制品质量标准”；然后在筛选出优良佐剂的基础上,取工作种子病毒库的病毒液,经4%o甲醛灭活后,按《中华人民共和国兽用生物制品质量标准》规定,将氢氧化铝胶佐剂和灭活的病毒按1∶9比例混匀,制备HEV细胞培养灭活疫苗。随机抽取实验室制备的疫苗以不同剂量接种Balb/c小鼠和怀孕母猪,结果该疫苗除了可以诱导良好的特异性免疫应答外,不产生任何临床副作用,说明本疫苗对小鼠和怀孕母猪是安全有效的；对注射疫苗后产生不同抗体效价的Balb/c小鼠进行脑内攻毒,结果当小鼠HI抗体效价≥25时,其保护率可达80%以上,且HI抗体效价滴度与免疫攻毒试验间存在良好的平行关系,可代替常规的攻毒保护率试验；将HEV灭活疫苗免疫Balb/c小鼠,结果小鼠经3次免疫后,HI抗体效价最高达29,进而通过血清亚类鉴定、淋巴细胞增殖实验、细胞因子检测等方法证实,该疫苗可刺激小鼠产生特异性的体液免疫应答,且以Th2型免疫应答为主；最后对疫苗的保存期进行评定,疫苗在2～8℃和室温(13℃～28℃)分别保存至12个月和4个月时,其物理性状及免疫效力未见变化,这与灭活疫苗稳定、便于保存运输的特点基本一致。由此可见,本实验制备的HEV灭活疫苗可安全有效的刺激机体产生特异性免疫应答,仔猪可通过经疫苗免疫的怀孕母猪产生HEV抗体,从而达到预防该病的目的,该疫苗的研制对HEV的防治有重要的现实意义。
Porcine hemagglutinating encephalomyelitis is an acute, highly contagious disease in piglets caused by the hemagglutinating encephalomyelitis virus (HEV). HEV belongs to the family of Coronaviridae, which included encephalomyelitis and Vomiting and wasting disease clinically type and mainly infects 1-to 3-week-old piglet causes vomiting, exhaustion, and neurological signs. The mortality rate varies from 20% to 100%. In 1962. the pathogen was isolated for the first time from suckling piglets suffering from encephalomyelitis in Canada. In 1972, the PHEV-VW572 strain was isolated from the tonsils of pigs that exhibited only vomiting and exhaustion symptoms, but no neurological signs. Serological surveys revealed that HEV infections in pigs are very common worldwide, most of the infected pigs in a sub-clinical state, once the disease, will cause huge economic losses. At present, various laboratory methods are available for the detection and surveillance of HEV. including virus isolation and identification, RT-PCR, nested PCR, hemagglutination and hemagglutination inhibition (HA and HI,respectively) tests, the enzyme-linked immunosorbent assay (ELISA). and the virus neutralization (VN) test. However, these detection methods are laborious, time-consuming, and require laboratory operations or special equipment, which makes these methods unsuitable for on-site inspection. As such, the current methods would not be useful for managing an outbreak of the disease. Therefore, it was necessary to develop a sensitive, specific, and easily performed detection method for on-site detection of HEV or HEV antibodies in order to increase the surveillance of HEV infections.
In recent years, with the monoclonal antibody (McAb) technology development and maturation, molecular biology, immunology, bacteriology, virology, biochemistry, genetics and many other fields have been widely used. Many diseases, diagnosis and differential diagnosis were established with the McAb.In this study, Balb/c mice were immunized subcutaneously with HEV purified by sucrose density gradient centrifugation, their splenic mononuclear cells were isolated and fused with murine myeloma cells (SP2/0). The hybridomas were generated through the selection of HAT medium and screened using Enzyme-linked immunosorbent assay (ELISA) and access to four single-secreting anti-HEV McAb, named 2H2,2A1,1E2,4D4. Identified,4 McAb ELISA titers between 1:12800 and 1:51200; subgroup identification,1E2 for the IgG2a,2H2、2A1 and 4D4 for the IgG1;Western blot analysis showed that 2H2,1E2 and 4D4 to recognize HEV hemagglutinin-esterase protein (HE),2A1 may recognize spike protein (S). Development of the sandwich ELISA with McAb 2A1 and 2H2 for detection HEV, the minimum could be detected 3.75μg/mL for HEV, and infection with the transmissible gastro-enteritis virus (TGEV), porcine Epidemic diarrhea (PEDV), porcine pseudorabies virus (PRV), Hogcholera virus (HCV) and bovine coronavirus (BCV) and so no cross reaction, wihich shows that the sandwich ELISA can be used for HEV detection.
Colloidal gold immunochromatographic assay (GICA) is a solid-phase immunoassay developed in the 1980s that combines the techniques of colloidal gold labeling, chromatographic analysis, immunodetection and other methods. Because of GICA's convenience and speed as well as its specificity and sensitivity and ability to be used without instruments or with only a simple instrument, it is suitable for clinical diagnosis and drug testing purposes and can be used anywhere.In this study, an immunochromatographic strip with high sensitivity and specificity was successfully developed for the detection of HEV. combining McAb and GICA.The colloidal gold particles were consistent in size and uniformly distributed, with a mean diameter of about 30nm when observed under a transmission electron microscope; monoclonal antibodies by gradient method to determine the best combination of colloidal gold pH 8.5, the best combination of a concentration of 37μg/mL. The colloidal gold-labeled MAb 2H2 solution was dispensed onto glass fiber paper at a speed of 50μl per cm using an XYZ3000 Dispense Workstation, and the MAb 2A1 or the goat anti-mouse antibody was dispensed at the test or the control line on the NC membrane using XYZ-3000; the sample pad, pretreated conjugate pad. NC membrane, and absorbent pads were glued together on a support board and assembled into a test strip.The immunochromatographic strip was capable of specifically detecting HEV with 30μg/mL within 10 min. Storage of the strips at room temperature for 6 months or at 4℃for 12 months did not change their sensitivity or specificity. Using RT-PCR and ELISA as reference test, the excellent agreement (98%; kappa= 0.956) between the results obtained by RT-PCR or ELISA and the immunochromatographic strips. Based on its high specificity, sensitivity, and stability, the immunochromatographic strip would be suitable for on-site detection of HEV for surveillance and epidemiological purposes.
An immunochromatographic strip was developed for the detection of an antibody against HEV. Colloidal gold-labeled rabbit anti-pig immunoglobulin G (IgG) was used as the detection reagent, and the HEV recombinant antigens and goat anti-rabbit IgG were coated on the prototype strip and the control lines, respectively. The immunochromatographic strip was capable of specifically detecting HEV antibodies in serum with a HI titer of 2 within 10 min. Storage of the strips at room temperature for 6 months or at 4℃for 12 months did not change their sensitivity and specificity. Using HI as a reference test, there was a strong agreement between the results obtained by HI and the immunochromatographic strips (kappa=0.911). Additionally, there was a strong agreement between ELISA and immunochromatographic strips (kappa=0.953). When the immunochromatographic strip was used for serological diagnosis of 672 serum samples in the Jilin and Liaoning province in China, the seropositivity ranged from 42.08% in Jinzhou District to 65.33% in Baishan District. Based on the high specificity, sensitivity, and stability of the immunochromatographic strip, it would be suitable for on-site detection of HEV antibodies in order to monitor HEV infections in an animal population.
Currently, there is no effect on the prevention or treatment of HEV drugs or vaccines has been reported, applied only in some countries abroad, "subclinical infection" of prevention, that is, one month before labor in sows contact with sick, spray or intramuscular injection training the attenuated HEV. When the sow immunitied, piglets gain the antibodies through colostrum, but it does not show clinical symptoms, most of these pigs showed a subclinical infection, and this immunological method exist clinical infection hidden danger. Therefore, the development of efficiently and safely vaccine against HEV prevention has important practical significance. In this study, based on HEV-67N strain as a vaccine candidate strains developed by optimizing the in vitro culture conditions to determine the HEV-67N PK-15 cells in culture and passage, using the nutrient medium with 0.4% BSA; establishment of PK-15 cells of the original seed cell banks (123～126 cells), based on the seed cell bank (127～136 cells) and the working seed cell bank (137～141 cells); the same time establish HEV-67N, respectively, the original seed virus database. foundation seed and working seed virus database virus database; random sample of the virus in the cell library and PK-15 cells and HEV-67N by microscopy, sterility test, mycoplasma detection and analysis of nucleic acids which adhere to "quality standards for veterinary biologics." In the adjuvant selected on the basis of quality, taking the virus working seed virus database solution, inactivated by 4‰formaldehyde, By "People's Republic of Veterinary Biological Products Quality Standards " provides, the aluminum hydroxide gel adjuvant and inactivated virus at 1:9 ratio of mixing, preparation HEV cell culture inactivated vaccine. Randomly selected the vaccine which prepared in labs Vaccination to Balb/cmice and pregnant sows, the results show that favourable specific immune response induced by the vaccine. The vaccine is also safe an effective to mice and pregnant sows. There is no adverse reaction happened on mice and sows after injecting the vaccine. On post-vaccination antibody titers have different Balb/c mice brain attack drugs, the protection rate is more than 80% when the mice's HI antibody titers≥2(?).There is satisfactory parallel relationship between HI antibody titers and immune attack drug test. It can replace convetional attack protection rate test. HEV inactivated vaccine inoculated Balb/c mice, HI antibody titers of mice up to 29 after the third immunization. The immune mice could produce specific humoral immune response certificated by serum sub-categories, lymphocyte proliferation, cytokines and other methods. The main of immune response is Th2 type. Finally, the preservation of the vaccines evaluated. The physical properties and immune effect of the vaccine was no change when the vaccine stored at 2-8℃for 12 months and room temperature (13℃-28℃) for 4 months.It basically the same characteristics as inactivated vaccine stability, ease of transportation and conservation. Thus, in this study, the body could produce specific immune response by the prepared HEV vaccine safely and efectively. Piglets generated the antibodies from the immunization of pregnant sows to achieve the purpose of preventing the disease.The vaccine has important practical significance to prevention of HEV
引文
[1]殷震，刘景华.动物病毒学[M].北京：科学出版社,1997：690-692.
[2]Vijgen L, Keyaerts E, Lemey P. et al. Evolutionary History of the Closely Related Group 2 Coronaviruses:Porcine Hemagglutinating Encephalomyelitis Virus, Bovine Coronavirus,and Human Coronavirus OC43[J]. J Virol.2006.14(80): 7270-7274.
[3]Chang GN. Chang TC, Lin SC. et al. Isolation and identification of hemagglutinating encephalomyelitis virus form pigs-in Taiwan[J]. J Chin Soc Vet Sci.1993.19:147-158.
[4]Wu HY. Guy JS. Yoo D, Vlasak R, Urbach E. Brian DA. Common RNA replication signals exist among group 2 coronaviruses:evidence for in vivo recombination between animal and human coronavirus molecules[J]. Virology. 2003,315(1):174-183.
[5]Ko CK, Kang MI, Lim GK, Kim GY, Yoon SS, Park JT, Jeong C, Park SH, Park SJ, Kim YJ. Jeong JH, Kim SK, Park SI, Kim HH, Kim KY, Cho KO. Molecular characterization of HE, M, and E genes of winter dysentery bovine coronavirus circulated in Korea during 2002-2003[J]. Virus Genes.2006,32(2):129-136.
[6]Greig AS. Mitchell D, Corner AHB, et al. A hemagglutinating virus producing encephalomyelitis in baby pigs [J]. Can J Comp Med.1962.26:49-56.
[7]Cartwright SF, Lucas M, Cavill PJ. et al.Vomiting and wasting disease of piglets[J]. Vet Rec,1969.84:175-176.
[8]Mengeling WL, Cutlip RC. Pathogenicity of field isolates of hemagglutinating encephalomyelitis virus for neonatal pigs[J].Am Vet Med Assoc,1976,168: 236-239.
[9]Sasseville AM, Gelinas AM, Sawyer N, et al. Biological and molecular characteristics of an HEV isolate associated with recent acute outbreaks of encephalomyelitis in Quebec pig farms [J]. Adv Exp Med Biol,2001,494:57-62.
[10]刘宝岩,薄清如.某猪场暴发冠状病毒性脑脊髓炎[J].兽医大学学报,1986,6(1)：84-87.
[11]徐汉祥.台湾省发生仔猪凝血性脑脊髓炎.畜牧兽医科技信息[J].1996，10：8.
[12]高丰,丁壮,张茂林,等.三个猪场暴发仔猪冠状病毒性脑脊髓炎[J].中国预防兽医学报,2000,22(2)：151-152.
[13]贺文琦,陆慧君，高丰,等.猪血凝性脑脊髓炎病毒抗体的调查[J].中国兽医科技,2005,35(9)：739-741.
[14]Quiroga MA, Cappuccio J, Pineyro P, et al. Hemagglutinating encephalomyelitis coronavirus infection in pigs,Argentina[J]. Emerg Infect Dis.2008,14(3): 484-486.
[15]贺文琦,陆慧君,宋德光,等.一株高致病性血凝性脑脊髓炎病毒的分离鉴定[J].中国兽医学报.2007.27(6)：781-784.
[16]Gonzalez JM, Gomez P, Cavanagh D, Gorbalenya AE, Enjuanes I. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae[J]. Arch Virol.2003.148:2207-2235.
[17]Greig AS, Johnson CM. Bouillant AMP. Encephalomyelitis of swine caused by a haemagglutinating virus VI. Morphology of the virus[J]. Res Vet Sci,1971,12: 305-307.
[18]Lamontagne I. Marois P. Marsolais G. Di Franco E. Assaf R. Inner structure of some coronaviruses[J]. Can J Comp Med,1981.45:177-181.
[19]Callebaut PE, Pensaert MB. Characterization and isolation of structural polypeptides in haemagglutinating encephalomyelitis virus[J]. J Gen Virol,1980, 48:193-204.
[20]Pocock DH. Garfwes FJ. The polypeptides of haemagglutinating encephalomyelitis virus and isolated subviral particles[J]. J Gen Virol,1977,37: 487-199.
[21]Vieler E, Schlapp T, Anders C, Herbst W. Genonlic relationship of porcine hemagglutinating encephalomyelits virus to bovine coronavirus and human conavirus OC43 as studied by the use of bovine coronavirus S gene-specific probes. Arch Virol.1995,140:1215-1223.
[22]Pensaert MB, Callebaut PE. Characteristics of a coronavirus causing vomition and wasting in pigs [J]. Arch Gesamte Virusforsch.1974,44(1):35-50.
[23]Yagami K. Hirai K, Hirano N. Patbogenesis of haemagglutinating encephalomyelitis virus (HEV) in mice experimentally infected by different routes[J]. J Comp Pathol.1986,96:645-657.
[24]Hirano N, Haga S, Fujiwara K. The route of transmission of hemagglutinating encephalomyelitis virus(HEV)67N strain in 4-week old rats[J]. Adv Exp Med Biol 1993,342:333-338.
[25]Girard A, Greig AS, Mitchell D. Encephalomyelitis of swine caused by a haemagglutinating virus.Ⅲ[J]. Serological studies. Research in Veterinary Science,1964,5:294-302.
[26]McFerran JB, Clarke JK, Connor TJ, Knox ER. Serological evidence of the presence of haemagglutinating encephalomyelitis virus in Northern Ireland[J]. Vet Rec,1971,88:339.
[27]Cartwright SE, Lucas M. Vomiting and wasting disease in piglets[J]. Vet Rec, 1970,86:278-280.
[28]Hirai K. Chang CN. Shimakura S. A serological survey on hemagglutinating encephalomyelitis virus infection in Japan[J]. Japanese Journal of Veterinary Science 1974,36 (5):375-380.
[29]Hess RG, Bachmann PA. Erbrechen und Kumern der Ferkeln.Vorkommen und Verbreitung in Suddeutschland[J]. Tieraertzl Umschau.1978,33:571-574.
[30]Mengeling WL. Incidence of antibody for hemagglutinating encephalomyelitis virus in serums from swine in the United States [J]. American Journal of Veterinary Research.1975,36:821-823
[31]Neuvonen E, Ek-Kommonen C. Veijalainen P,Schulman A. Absence of hemagglutinating encephalomyelitis virus in Finnish elite breeding pig herds [J]. Nord Vet Med,1982,34:334-335.
[32]贺文琦,陆慧君,耿百成,宋德光,姜宁,Hirano N,高丰.猪血凝性脑脊髓炎病毒抗体的调查[J].中国兽医科技，2005.35(9)：739-741.
[33]赵传博,陈克研,贺文琦,周铁忠,.陆慧君,王丽,李赫,高丰.猪血凝性脑脊髓炎病毒的血清学调查[J].中国畜牧兽医,2009，36(7)：152-154.
[34]周铁忠,李晓卫,李永深,周洪臣,刘丽颖,李敏,陈克研,许冰营,高丰.辽宁省猪血凝性脑脊髓炎流行病学调查与分析[J].中国农学通报,2009.25(18)：13-17
[35]BE斯特劳.猪病学[M].第九版,赵德明.张仲秋.主译.北京：中国农业大学出 版社,2000,710-717.
[36]Hoorens J, Thoonen H, Gheyle M. Braakziekte bij biggen[J]. Vlaams Diergeneeskd Tijdschr,1977,46:209-224.
[37]Sasaki I, Kazusa Y, Shirai J. et al. Neutralizing test of hemagglutinating encephalomyelitis virus (HEV) in FS-L3 cells cultured without serum[J]. J Vet Med Sci,2003,65:381-383.
[38]Rimmelzwaan GF, Juntti N. Evaluation of enzyme-linked immunosorbent assays based on monoclonal antibodies for the serology and antigen detection in canine parvovirus infections [J]. Vet Q.1990,12(1):14-20.
[39]陈克研,赵传博,贺文琦,陆慧君.高巍.常志广,王丽,高丰.猪血凝性脑脊髓炎病毒单克隆抗体的制备与鉴定[J].中国生物制品学杂志，2009，22(9)：907-910.
[40]Tuchyia K,Kasaoka T,Azetaka M,Takahashi E,Konishi S.Plaque assay for canine coronavirus in CRFK cells[J]. Jpn J Vet Sci,1987:571-573.
[41]Rimmelzwaan GF, Groen J, Egcerink H, Borst G H A, Ugtdehaay F G G.M,Osterhaus A D. The use of enzyme-linked immunosorbant assay systems for serology and antigen detection in parvovirus.coronavirus and rotavirus infections in dogs in the Netherlands [J]. Veterinary Microbiology,1991,6:25-40.
[42]Andries K, Pensaert M. Propagation of hemagglulinating encephalomyelitis virus in porcine cell cultures[J]. Zentralbl Veterinarmed B,1980.27:280-290.
[43]Wood R D. Efficiency of a Transmissible Gastroenteritis Coronavirus with an Altered ORF3 gene[J].Can J Vet Res,2001.65(1):28-32.
[44]李军,林继煌,姜平等.用免疫胶体金技术检测猪繁殖与呼吸综合征病毒[J].畜牧与兽医,2001,33(2)：1-2.
[45]Sekiguchi Y, Shira J, Taniguchi T, et al. Development of reverse transcriptase PCR and nested PCR to detect porcine hemagglutinating encephalomyelitis virus. J Vet Med Sci[J],2004,66(4):367-372.
[46]王世若,王兴龙,韩文瑜.现代动物免疫学[M].吉林：科学技术出版社,2001,418-419.
[47]Elia Q, Fiermonte, Pratelli A, et al. Recombinant M protein-based ELISA test for detection of antibodies to canine coronavirus [J]. J Virol Methods. 2003.109(2):139-142.
[48]李凌,马文丽.DNA芯片技术研究进展[J].中国生物化学与分子生物学报, 2000,16(2):151-155.
[49]石嵘,马文丽,刘翠华,等.两种限制性标记方法提高基因芯片杂交结果的信噪比[J].第一军医大学学报,2003,23(2)：124-126.
[50]Marra MA, Jones SJ, Astell CR, etal. The Genome Sequenee of the SARS assoeiated Coronavirus[J]..Seienee,2003,300(5624):1399-1404.
[51]张延龄,张辉.疫苗学[M].北京：科学出版社,2004：137-147.
[52]王明俊.兽医生物制品学[M].北京：中国农业出版社,1996：378-484.
[53]宁宜宝.兽用疫苗学[M].北京：中国农业出版社,2008：16-27.
[54]Yamanouchi K, Barret T, Kai C. New approaches to the development of virus vaccines for veterinary use[J]. Rev Sci Tech Off Int Epiz,1998(17):641-653.
[55]Pastoret P. Veterinary vaccinology[J]. C R Acad Sci,1999(322):967-972.
[56]夏咸柱,余春，黄耕,胡桂学,王允海,王长金.犬冠状病毒BEI灭活苗的制备与免疫试验[J].中国兽医杂志，2001，3(37)：37-38
[57]余春,夏咸柱,池元斌,张春红,黄耕,范泉水,何洪彬，王允海，刘海涛.犬冠状病毒压力灭活苗的制备与应用[J].研究中国兽医科技,2000,,5(30)：5-8
[58]William M A, Bobby E, John W B, et al. Canine Coronavirus Vaccine[A]. U nited States Patent.4567043,1986,1-28.
[59]马思奇,王明,周金法,等.猪流行性腹泻病毒适应Vero细胞及以传代细胞毒制备氢氧化铝灭活疫苗免疫效力试验[J].中国畜禽传染病,1994(2)：15-19.
[60]王俊东,蔡建平主编.畜禽群发性疾病防治[M].北京：中国农业出版社,2002,397-413
[61]Park. Eseors D, Ortego J, Enjuanes L. The membrane M Proteinear boxyter minalbinds to transmissible gastroenteritiseorona virus core and contributes to ceore stability[J]. J Virol,2001,75(3):1312-1324.
[62]童昆周,李力复,林志雄,等,猪流行性腹泻弱毒疫苗的研究[J].中国兽医科技,1996，26(1)：3-4.
[63]周仲方,冯力,李伟杰,等.猪传染性胃肠炎与猪流行性腹泻二联弱毒疫苗的研究[J].中国预防兽医学报,2002,21(6)：406-410.
[64]Edwards B G, Fulker R H. A cree W M. Evaluating a caninecoronavirus through antigen extinction and challenge studies[J]. Veterinary Medicine,1985,80 (28):30-33.
[65]Barry J. A corn-based delivery system for animal vaccines:an oral transmissible gastroenteritis virus vaccine boosts lacto genic immunity in swine[J].Vaccine. 2004,22:2420-2424.
[66]Siler CA,McGettigan JP, Dietzschold B, et al. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines. Virology,2002.292: 24-34.
[67]Garwes D J, Lucas M H, Higgins D A. Antigenicity of structural components from porcine transmissible gastroenteritis virus[J].Vet Microbiol,1983,1:37-41.
[68]Godet M. Rasschaert D. Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculo virus[J]. Virology,1991,18(2):732-740.
[69]Shoup D I. Jackwood D J. Saif L J. Active and passive immune responses to transmissible gastroenteritis virus(TGEV) in swine inoculated with recombinant baculovirus-expressed TGEV.spike coprotein vaccines[J]. Am J Vet Res,1997,8(3):242-250.
[70]Tsuji M, Bergmann C C,Takita-Sonoda Y, et al. Recombinant sindbis viruses expressing a cytotoxic T lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice [J]. J Virol,1998,72:6907-6910.
[71]李忠明.当代新疫苗[M].北京：中国科学出版社，2003.48-78.
[72]Nakaya T. Cros J, Park MS, et al. Recombinant Newcastle disease virus as a vaccine vector. J. Virol.,2001.75:11868-11873
[73]Riffault, Pulfoul D J,Brittonp. Expression and cellular loealisation of poreine transmissible gastroenteritis virus N and MP roteins by recombinant vaccine viruses[J]. Virus Res,1991,18(2-3):203-217.
[74]Tamas. Plana Duran, Collins J E, Mengling W L. Efficacy of aninactived vaccine for Prevention of reproductive failure induced by porinere productive and respiration syndrome viru[J].Vet Microbiol,1997,55:361-370.
[75]Zakhartchouk, Godet M, Rasschaert D and anchor-free spike glycoprotein S Laude H. Processing and antigenicity of entire and of coronavirus SARS expressed by recombinant baculovirus[J]. Virology,1991.185(2):732-740.
[76]Tuboly T. Nagy E, Shinzato T. Immunogenicity of the Sprotein of transmissible gastroenteritis virus expressed in baculovirus[J].Arch Virol.1994,137:66-67.
[77]Song,Anton IM, Gonzalez S, Bullido MJ. Cooperation between IBV structural proteins in the in vitro induction of virus-specif c antibodies [J]. Virus Res.1996. 46(1-2):111-124.
[78]Wang X. Tomes JM, Sanchez C. Sune C. Induction of antibodies protecting against IBV by recombinant adenovirus expressing TGEV spike protein [J]. Virology,1995,213(2):5013-5016.
[79]Tuboly T and Nagy E. Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene [J]. J Gen Virol,2001,82(1):183-190.
[80]李琦涵.刘龙丁,车艳春.疫苗关键技术详解[M].北京，化学工业出版社,2006，41-51.
[81]Liu C, Kokuho T, Kubota T, et al. DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus [J]. Virus Res,2001,80(1-2):75-82.
[82]Annette Malene Barfoed. Fernando Rodriguez,Dominic Therrien et al. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/cmice. Antiviral Research,2006, (72):178-189.
[83]Riffault S, Baric R, Levyl. In vivo induction of inferonalpha in pig by non-infections coronavirus:tissue localization and in situ phenotypic characterization of inferonala producing cells[J]. Journal of General Virology,1997,78(10):2483-2487.
[84]Motokama K. Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, inteyral membrance and nucleocapsid protein of feline,canine and porcine coronavirus[J]. Microbiology and Immuunology,1996, 40(6):425-433.
[85]Tuboly T, Nagy E, Dennis J R, Derbyshire J B. Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculo virus[J]. Arch Virol,1994,137:60-67.
[86]任晓峰,尹杰超,李一经,等.猪传染性胃肠炎病毒TH298株S基因核酸疫苗的构建及其免疫效力[J].中国兽医科学.2006，36(3)：203-206.
[87]Scott C, Weaver, Thomas W. Molecular evolution of eastern quine encephalomyelitis virus in North America[J].Virolog,1991,182(2):774-784.
[88]Gomez N. Carrillo C, Salinas J. Expression of Immunogenic Glycoprotein from Transmissible Gastroenteritis Coronavirusiy[J].Virology,2009,249(2):332-356.
[89]徐志凯.实用单克隆抗体技术[M].西安：陕西科学技术出版社,1991：125-126.
[90]张昶,任向阳,刘秋燕，等.单克隆抗体在畜禽疫病诊断中的应用.中国畜牧兽医,2007，34(5)：93-95
[91]许慧,倪安平.单克隆抗体及基因工程抗体在医学诊断上的应用.中华检验医学杂志,2005,28(6)：669-672
[92]沈关心，周汝麟.现代免疫学实验技术[M].第2版.武汉：湖北科学技术出版社,2001：32-37.
[93]朱立平,陈学清.免疫学常用实验方法[M].北京：人民军医出版社,2000.188-189
[94]Zhang Y,Rameshwer D S,Prem S P, et al.Monoclonal antibodies against conformationally dependent epitopes on porcine reproductive and respiratory syndrome [J].Veterinary microbiology,1998,73:125-136.
[95]徐志凯.实用单克隆抗体技术[M].西安：陕西科学技术出版社,1991：125-126.
[96]Milstein, Zhang YZ, Xiong CL, Zou Y, et al. Molecular characterization of rabies virus isolates in China during 2004. Virus Res.2006,121(2):79-88.
[97]Liddel J E, Cryer A. A practical guide to monoclonal antibodies[M]. Chichester: John Wiley, Sons Ltd,1991.
[98]Barski, Harty RN, Brown ME, et al. Rhabdoviruses and the cellular ubiquitin proteasome system:a budding interaction [J].J Virol.2001,75(22):10623-9.
[99]Okada, Harty RN, Paragas J, et al. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins:implications for viral budding [J]. J Virol.1999,73(4):2921-9
[100]高尚先,王玉琴,李修兰,等.大鼠抗-HBs的单克隆抗独特型抗体杂交瘤细胞系的建立[J].中国免疫学杂志，1993,9(2)：80-83.
[101]张昶,任向阳,刘秋燕,等.单克隆抗体在畜禽疫病诊断中的应用[J]..中国畜牧兽医,2007，34(5)：93-95.
[102]许慧,倪安平.单克隆抗体及基因工程抗体在医学诊断上的应用.中华检验医学杂志,2005，28(6)：669-672.
[103]Yang J. Koprowski H, Dietzschold B. et al. Phosphorylation of rabies virus nucleoprotein regulates viral RNA transcription and replication by modulating leader RNA encapsidation[J]. J Virol.1999,73(2):1661-1664.
[104]Mebatsion T, Weiland F, Conzelmann KK. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G [J]. J Virol.1999,73(1):242-50.
[105]Heeschen C, Goldmann BU, Moeller RH, Hamm CW. Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I [J]. Clin Chem 1998.44:1925-1930.
[106]Laderman EI, Whitworth E. Dumaual E, et al. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood [J]. Clin Vaccine Immunol.2008,15:159-163.
[107]Zarakolu P, Buchanan I, Tam M, et al. Preliminary evaluation of an immunochromatographic strip test for specific Treponema pallidum antibodies [J]. J Clin Microbiol.2002.40:3064-3065.
[108]Grabar KC, Freeman RG. Hommer MB, et al. Preparation and characterization of Au colloid monolayers[J]. Anal Chem.1995,67:735-743.
[109]Arens MQ, Mundy LM, Amsterdam D, et al. Preclinical and clinical performance of the Efoora test, a rapid test for detection of human immunodeficiency virus-specific antibodies [J]. J Clin Microbiol.2005.43: 2399-2406.
[110]Biagini RE, Sammons DL, Smith JP, et al.:Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood[J]. Clin Vaccine Immunol. 2006,13:541-546.
[111]马红艳.胶体金诊断试剂盒中层析膜材料性能的分析.膜科学与技术.2002,22(6)：14-18.
[112]Viera AJ, Garrett JM. Understanding interobserver agreement:the kappa statistic[J]. Fam Med.2005,37:360-363.
[113]Dea S, Tijssen P. Detection of turkey enteric eoronavirus by enzyme linked immunosorbent assay and differentiation from other coronaviruses[J]. Am J Vet Res.1989.50:226-231.
[114]李永勤等.以膜为固体载体的免疫胶体金快速试验[M].微生物免疫学进展,2003,31(1).
[115]Bassab C, Syamal R. Manufacturing high quality gold sol[J]. IVD Technology 2001.8:46254.
[116]Chandler J,Gurmin T. The place of gold in rapid tests [J]. IVD Technology 2000,6:37249.
[117]Faulkh L, Taylor P. Fidanza N,etal. Single-step method forrap id detection of Brucella spp in soft cheese by gene-specific polymerase chain reaction[J]. J Dairy Res,1999,66(2):313-317
[118]Hermanson GT. Bioconjugate techniques[M]. Academic press,1996,593-602.
[119]Zhang GP, Guo JQ. Wang XN, et al.:Development and evaluation of an immunochromatographic strip for trichinellosis detection[J]. Vet Parasitol.2006, 137:286-293.
[120]Murphy FA. Paul J. Marian C. Veterinary Virology (Thirdedition)[M]. New York:Academic Press,1999.459-468.
[121]Henk L, Theresia H, Abdoel, Javier Solera, etal. Immunochromatographic Brucella-Specific Immunoglobulin Mand G Lateral Flow Assays for Rapid Sero diagnosis of Human Brucellosis[J]. Clinical and Diagnostic Laboratory,2003, 11:1141-1146
[122]Millipore, A short guide developing immunochromatographic test strips,2ed edition. Millipire Corparation, Bedford, MA,1999. p.2.
[123]Mildbrand, MM, Teramoto, YA, Collins, JK., et al.Rapid detection of canine parvovirus in feces using monoclonal antibodies and enzyme-linked immunosorbent assay [J]. Am J Vet Res.1984.45(11):2281-2284.
[124]Rimmelzwaan GF, Juntti N., et al. Evaluation of enzyme-linked immunosorbent assays based on monoclonal antibodies for the serology and antigen detection in canine parvovirus infections[J]. Vet Q.1990,12(1):14-20.
[125]何启强,杨进波,肖成峰,等.双抗夹心ELISA法检测血浆HSP70的建立及初步应用[J].环境与职业医学.2004,21(1)：24-26.
[126]吴保存,荆汝顶.确定ELISA试验阳性临界值的探讨[J].中国动物检疫,1994,11(5)：15-16.
[127]Cliquet F, McElhinney LM. Development of a qualitative indirect ELISA for the measurement of rabies virus-specific antibodies from vaccinated dogs and cats[J]. J Virol Methods.2003.117:1-8.
[128]Sato K, Inaia Y, Miura Y, Tokuhisa S, Matumoto M. Inducement of cytopathic changes and plaque for mation by porcine haemagglutinaling encephalomyelit virus[J]. Vet Microbiol.1983,8:521-530.
[129]Mengeling W, Coria MF. Buoyant density of hemagglutinating encephalomyelitis of swine:Comparison with avian bronchitis virus[J]. Am J Vet Res.1972,33:1359-1363.
[130]Hoorens J, Thoonen H, Gheyle M. Buyten A. Braakziekte bij biggen[J]. Vlaams Diergeneeskd Tijdschr[J].1977,46:209-224.
[131]Paul PS, Mengeling WI. Persistence of passivelyacquired antihodies to haemagglutinating encephalomyelifts virus in swine[J]. Am J Vet Res,1984,45: 932-934.
[132]Hirano N. Suzuki Y. Haga S. Pigs with highly prevalent antibodies to human coronavirus and swine haemagglutinating encephalomyelitis virus in the Tohoku District of Japan[J]. Epidemiol infect,1999,122:545-551.
[133]Hirano N, Nomura R, Tawara T,et al. Neurotropism of swine haemagglutinating encephalomyelitis virus (coronavirus) in mice depending upon host age and route of infection[J]. J Comp Pathol.2004,130(1):58-65.
[134]Hirano N, Tohyama K, Taira H. Spread of swine hemagglutinating encephalomyelitis virus from peripheral nerves to the CNS[J]. Adv Exp Med Biolo,1998,440:601-607.
[135]Sekiguchi Y, Shirai J. Taniguchi T, et al. Development of reverse transcriptase PCR and nested PCR to detect porcine hemagglutinating encephalomyelitis virus[J].J Vet Med Sci.2004,66(4):367-372.
[136]常灵竹,贺文琦,陆慧君.等.猪血凝性脑脊髓炎病毒RT-PCR方法的建立及初步应用[J].中国农学通报.200723(9)：15-18.
[137]耿百成,高丰,贺文琦.等.血凝性脑脊髓炎病毒血凝抑制试验方法的研究[J].动物医学进展.2005,26(6)：98-100.
[138]Oliver C. Conjugation of colloidal giold to proteins[J].Methods Mol Biol.1999, 115:331-334.
[139]Mena M L. Yanez-Sedeno P. Pingarron J M. A comparison of different strategies for the construction of amperometric enzyme biosensors using gold nanoparticle modified electrodes[J]. Anal Biochem.2005,336(1):20-27
[140]Tang D, Yuan R, Ch Y. etal. A novel immunosensor based on immobilization of hepatitis B surface antibody on platinum electrode modified colloidal gold and polyvinyl butyral as matrices via electrochemical impedance spectroscopy [J]. Bioelectrochemistry,2004,65(1):15-22.
[141]Yang J, Qunyi H, Huanchun,Jian L, Zhou. Development and evaluation of an immunochromatographic strip for the detection of serum antibodies against bluetongue virus[J]. Journal of Virological Methods.2010,163:68-73.
[142]Akaike Y, Miyahara T. SPF swine repopulation program. Japan SPF Swine Association edition, Chikusan Syuppan Co Tokyo. In:Pig Health Control. 1985.134-148.
[143]Trebeden H. Goffinet F. Kayem G. Maillard F, Lemoine E, Cabrol. D. Strip test for bedside detection of interleukin-6 in cervical secretions is predictive for impending preterm delivery[J]. Eur Cytokine Netw.2001.12:359.
[144]Kayem G, Goffinet F, Batteux F, Jarreau PH. Weill B. Detection of interleukin-6 in vaginal secretions of women with preterm premature rupture of membranes and its association with neonatal infection:a rapid immunochromatographic test[J]. Am J Obstet Gynecol.2005,192:140.
[145]Zhang GP, Guo JQ, Wang XN, Yang JX, Yang YY, Li QM, Li XW, Deng, RG. Development and evaluation of an immunochromatographic strip for trichinellosis detection[J]. Vet Parasitol.2006,137:286-293.
[146]Faulk WP, Taylor GM. An immunocolloid method for the electron microsco[J]. Immunochemistry.1997.8:1081-1083.
[147]Huang ZW. Zhu G. Szekeres H. Xia. Development of new rabbit monoclonal antibody to estrogen receptor:immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue section[J]. Appl Immunohistochem Mol Morphol.2005,13:91-95.
[148]Vaughn XL. Shi XE, Jin N, Xiong FH, Peng DP. Development and validation of an immunochromatographic assay for rapid detection of sulfadiazine in eggs and chickens[J]. J Chromatogr.2007,847:289-295.
[149]Yagami K, lzunli Y, Kajiwara N, Sugiyama F, Sugiyama Y. Neurotropism of mouse-adapted haemagglutinating encephalomyelitis virus[J]. J Comp Pathol. 1993.09:21-77.
[150]Schuhze B, Herrler G. Recognition of N acetyl-9-O-acetylneLlraminic acid by bovine coronavirus and hemagglutinating enceptlalonlyelitis Virus [J]. AdV Exp Med Bi0.1993,342:299-304.
[151]Sasseville AM, Boutin M, Gelinas AM, Dea S. Seauence of the 3*-terminal end(8.1 kb)of the genome of porcine haemagglutinating encephalomyelitis virus: Comparison with other haemagglutlnatlng coronavirus[J]. J Gen Virol.2002.83: 2411-2416.
[152]Appel M, Greig AS, Corner AH. Encephalomyelitis of swine caused by a haemagglutinating virus. Ⅳ[J]. Transmission studies Res Vet Sci.1965,6: 482-499.
[153]Hirano N, Ono K, Takasawa H, Murakami T, Haga S. Replication and plaque formation of swine haemagglutinating encephalomyelitis virus(67N)in swine cell line, SK-K culture[J]. J Virol Methods.1990.27:91-100.
[154]Sorensen KJ. Henlagglutinating encephalomyelit virus(HEV)infections in swine. Serologic indication for infectional occurrence in Denmark. Haemagglulinerende encephalomyelitis virus(HEV)infektioner hosgrise. Serologisk indikation for infektionens tilstedevaerelse i Denmark[J]. Nord Vet Med.1975,27:208-212.
[155]Vannier P, Chappuis G. Labadie JL. Renault L, Josse J. A serological survey of the virus of vomiting and wasting disease in piglets[J]. Ann Zootecb.1981,30: 379.
[156]Clements CJ and Griffiths E. The global impact of vaccines containing aluminium adjuvants[J]. Vaccine.2002,20 (Suppl.3):S24.
[157]Dong DX, Li QH. Foundation and application of vaccine technology [J]. Science Press. Peking of China.2002.149.
[158]HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants[J]. Vaccine.2002,20 (Suppl.3):S34.
[159]Prince GA, Denamur F. Deschamps M. Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease[J].Vaccine.2001,19 (15-16):2048.
[160]王大庆,于庆海,周园，等.现代免疫佐剂研究[J].中国免疫学杂志.2006.22 (2)：189-190.
[161]董德祥,李琦涵,褚嘉.疫苗技术基础与应用[M].北京：化学工业出版社,2002：149.
[162]Srivastava AK, Putnak, JR,Lee SH. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells[J]. Vaccine,200119 (31):45-57.
[163]陈光化.兽用新生物制品[J].中国禽业导刊.2002,19(14)：4-16.
[164]Nicklas W. Aluminum salts.Res Immunol[J].1992,143 (5):489-494.
[165]Clements CJ, Griffiths E. The global impact of vaccines containing aluminium adjuvants[J]. Vaccine.2002,20 (Suppl.3):S24.
[166]Dong DX, Li QH. Foundation and application of vaccine technology [J]. Science Press, Peking of China.2002,149.
[167]Weiss RC. Scott FW. Antibody-mediated enhancement of disease in feline infectious peritonitis:comparisons with dengue hemorrhagic fever[J]. Comp. Immunol. Microbiol. Infect. Dis.1981.4:175.
[168]Singh M, O'Hagan D. Advances in vaccine adjuvants[J]. Nat. Biotechnol.1999, 17:1075.
[169]Jordan MB, Mills DM, Kappler J, Marrack P. Cambier JC. Promotion of B cell immune responses via an aluminduced myeloid cell population[J]. Science.2004, 304:1808.
[170]Nicollier-Jamot B, Ogier A, Piroth L, Pothier P, Kohli E. Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in Balb/cmice induce specific humoral and cellular Thl/Th2-like immune responses[J]. Vaccine.2004, 22:1079.
[171]Bourgeois CH, Veiga-Fernandes AM, Joret B. Rocha C. Tanchot. CD 8 lethargy in the absence of CD 4 help[J]. Eur J Immunol.2002,32:2199-2207.
[172]Harty JT. Tvinnereim D W,White. CD 8+T cell effector mechanisms in resistance to infection[J]. Annu Rev Immunol.2000,18:275-308.
[173]Jordan MB, Mills DM, Kappler J. Marrack P. Cambier JC. Promotion of B cell immune responses via an aluminduced myeloid cell population[J]. Science. 2004,304:1808.
[174]Pope M, Chung SW, Mosmann T, Leibowitz JL. Gorczynski RM, Levy GA. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Thl. but not a Th2, response, whereas pre-existing antibody partially protects against primary infection[J]. J. Immunol.1996,156:3342.
[175]Wu CKJ. Rotte. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo[J]. Nat. Immunol.2002,3:852-831.
[176]Wu GF. Dandekar AA,Pewe L. Perlman S. The role of CD4 and CD8 T cells in MHV-JHM-induced demyelination[J]. Adv. Exp. Med. Biol.2001.494:341.
[177]Kelly E, Won Y. Refaeli L, Van Parijs. IL-2 and related cytokines can promote T cell survival by activating AKT 1[J]. J. Immunol.2002,168:597-603.
[178]Ren ZW. Li M. LLJP. The produce technology of SPF pig were application of modern raising pig in China[J]. Ani Sci and Med Sci.2001,18(4):56-58.
[2]Vijgen L, Keyaerts E, Lemey P. et al. Evolutionary History of the Closely Related Group 2 Coronaviruses:Porcine Hemagglutinating Encephalomyelitis Virus, Bovine Coronavirus,and Human Coronavirus OC43[J]. J Virol.2006.14(80): 7270-7274.
[3]Chang GN. Chang TC, Lin SC. et al. Isolation and identification of hemagglutinating encephalomyelitis virus form pigs-in Taiwan[J]. J Chin Soc Vet Sci.1993.19:147-158.
[4]Wu HY. Guy JS. Yoo D, Vlasak R, Urbach E. Brian DA. Common RNA replication signals exist among group 2 coronaviruses:evidence for in vivo recombination between animal and human coronavirus molecules[J]. Virology. 2003,315(1):174-183.
[5]Ko CK, Kang MI, Lim GK, Kim GY, Yoon SS, Park JT, Jeong C, Park SH, Park SJ, Kim YJ. Jeong JH, Kim SK, Park SI, Kim HH, Kim KY, Cho KO. Molecular characterization of HE, M, and E genes of winter dysentery bovine coronavirus circulated in Korea during 2002-2003[J]. Virus Genes.2006,32(2):129-136.
[6]Greig AS. Mitchell D, Corner AHB, et al. A hemagglutinating virus producing encephalomyelitis in baby pigs [J]. Can J Comp Med.1962.26:49-56.
[7]Cartwright SF, Lucas M, Cavill PJ. et al.Vomiting and wasting disease of piglets[J]. Vet Rec,1969.84:175-176.
[8]Mengeling WL, Cutlip RC. Pathogenicity of field isolates of hemagglutinating encephalomyelitis virus for neonatal pigs[J].Am Vet Med Assoc,1976,168: 236-239.
[9]Sasseville AM, Gelinas AM, Sawyer N, et al. Biological and molecular characteristics of an HEV isolate associated with recent acute outbreaks of encephalomyelitis in Quebec pig farms [J]. Adv Exp Med Biol,2001,494:57-62.
[10]刘宝岩,薄清如.某猪场暴发冠状病毒性脑脊髓炎[J].兽医大学学报,1986,6(1)：84-87.
[11]徐汉祥.台湾省发生仔猪凝血性脑脊髓炎.畜牧兽医科技信息[J].1996，10：8.
[12]高丰,丁壮,张茂林,等.三个猪场暴发仔猪冠状病毒性脑脊髓炎[J].中国预防兽医学报,2000,22(2)：151-152.
[13]贺文琦,陆慧君，高丰,等.猪血凝性脑脊髓炎病毒抗体的调查[J].中国兽医科技,2005,35(9)：739-741.
[14]Quiroga MA, Cappuccio J, Pineyro P, et al. Hemagglutinating encephalomyelitis coronavirus infection in pigs,Argentina[J]. Emerg Infect Dis.2008,14(3): 484-486.
[15]贺文琦,陆慧君,宋德光,等.一株高致病性血凝性脑脊髓炎病毒的分离鉴定[J].中国兽医学报.2007.27(6)：781-784.
[16]Gonzalez JM, Gomez P, Cavanagh D, Gorbalenya AE, Enjuanes I. A comparative sequence analysis to revise the current taxonomy of the family Coronaviridae[J]. Arch Virol.2003.148:2207-2235.
[17]Greig AS, Johnson CM. Bouillant AMP. Encephalomyelitis of swine caused by a haemagglutinating virus VI. Morphology of the virus[J]. Res Vet Sci,1971,12: 305-307.
[18]Lamontagne I. Marois P. Marsolais G. Di Franco E. Assaf R. Inner structure of some coronaviruses[J]. Can J Comp Med,1981.45:177-181.
[19]Callebaut PE, Pensaert MB. Characterization and isolation of structural polypeptides in haemagglutinating encephalomyelitis virus[J]. J Gen Virol,1980, 48:193-204.
[20]Pocock DH. Garfwes FJ. The polypeptides of haemagglutinating encephalomyelitis virus and isolated subviral particles[J]. J Gen Virol,1977,37: 487-199.
[21]Vieler E, Schlapp T, Anders C, Herbst W. Genonlic relationship of porcine hemagglutinating encephalomyelits virus to bovine coronavirus and human conavirus OC43 as studied by the use of bovine coronavirus S gene-specific probes. Arch Virol.1995,140:1215-1223.
[22]Pensaert MB, Callebaut PE. Characteristics of a coronavirus causing vomition and wasting in pigs [J]. Arch Gesamte Virusforsch.1974,44(1):35-50.
[23]Yagami K. Hirai K, Hirano N. Patbogenesis of haemagglutinating encephalomyelitis virus (HEV) in mice experimentally infected by different routes[J]. J Comp Pathol.1986,96:645-657.
[24]Hirano N, Haga S, Fujiwara K. The route of transmission of hemagglutinating encephalomyelitis virus(HEV)67N strain in 4-week old rats[J]. Adv Exp Med Biol 1993,342:333-338.
[25]Girard A, Greig AS, Mitchell D. Encephalomyelitis of swine caused by a haemagglutinating virus.Ⅲ[J]. Serological studies. Research in Veterinary Science,1964,5:294-302.
[26]McFerran JB, Clarke JK, Connor TJ, Knox ER. Serological evidence of the presence of haemagglutinating encephalomyelitis virus in Northern Ireland[J]. Vet Rec,1971,88:339.
[27]Cartwright SE, Lucas M. Vomiting and wasting disease in piglets[J]. Vet Rec, 1970,86:278-280.
[28]Hirai K. Chang CN. Shimakura S. A serological survey on hemagglutinating encephalomyelitis virus infection in Japan[J]. Japanese Journal of Veterinary Science 1974,36 (5):375-380.
[29]Hess RG, Bachmann PA. Erbrechen und Kumern der Ferkeln.Vorkommen und Verbreitung in Suddeutschland[J]. Tieraertzl Umschau.1978,33:571-574.
[30]Mengeling WL. Incidence of antibody for hemagglutinating encephalomyelitis virus in serums from swine in the United States [J]. American Journal of Veterinary Research.1975,36:821-823
[31]Neuvonen E, Ek-Kommonen C. Veijalainen P,Schulman A. Absence of hemagglutinating encephalomyelitis virus in Finnish elite breeding pig herds [J]. Nord Vet Med,1982,34:334-335.
[32]贺文琦,陆慧君,耿百成,宋德光,姜宁,Hirano N,高丰.猪血凝性脑脊髓炎病毒抗体的调查[J].中国兽医科技，2005.35(9)：739-741.
[33]赵传博,陈克研,贺文琦,周铁忠,.陆慧君,王丽,李赫,高丰.猪血凝性脑脊髓炎病毒的血清学调查[J].中国畜牧兽医,2009，36(7)：152-154.
[34]周铁忠,李晓卫,李永深,周洪臣,刘丽颖,李敏,陈克研,许冰营,高丰.辽宁省猪血凝性脑脊髓炎流行病学调查与分析[J].中国农学通报,2009.25(18)：13-17
[35]BE斯特劳.猪病学[M].第九版,赵德明.张仲秋.主译.北京：中国农业大学出 版社,2000,710-717.
[36]Hoorens J, Thoonen H, Gheyle M. Braakziekte bij biggen[J]. Vlaams Diergeneeskd Tijdschr,1977,46:209-224.
[37]Sasaki I, Kazusa Y, Shirai J. et al. Neutralizing test of hemagglutinating encephalomyelitis virus (HEV) in FS-L3 cells cultured without serum[J]. J Vet Med Sci,2003,65:381-383.
[38]Rimmelzwaan GF, Juntti N. Evaluation of enzyme-linked immunosorbent assays based on monoclonal antibodies for the serology and antigen detection in canine parvovirus infections [J]. Vet Q.1990,12(1):14-20.
[39]陈克研,赵传博,贺文琦,陆慧君.高巍.常志广,王丽,高丰.猪血凝性脑脊髓炎病毒单克隆抗体的制备与鉴定[J].中国生物制品学杂志，2009，22(9)：907-910.
[40]Tuchyia K,Kasaoka T,Azetaka M,Takahashi E,Konishi S.Plaque assay for canine coronavirus in CRFK cells[J]. Jpn J Vet Sci,1987:571-573.
[41]Rimmelzwaan GF, Groen J, Egcerink H, Borst G H A, Ugtdehaay F G G.M,Osterhaus A D. The use of enzyme-linked immunosorbant assay systems for serology and antigen detection in parvovirus.coronavirus and rotavirus infections in dogs in the Netherlands [J]. Veterinary Microbiology,1991,6:25-40.
[42]Andries K, Pensaert M. Propagation of hemagglulinating encephalomyelitis virus in porcine cell cultures[J]. Zentralbl Veterinarmed B,1980.27:280-290.
[43]Wood R D. Efficiency of a Transmissible Gastroenteritis Coronavirus with an Altered ORF3 gene[J].Can J Vet Res,2001.65(1):28-32.
[44]李军,林继煌,姜平等.用免疫胶体金技术检测猪繁殖与呼吸综合征病毒[J].畜牧与兽医,2001,33(2)：1-2.
[45]Sekiguchi Y, Shira J, Taniguchi T, et al. Development of reverse transcriptase PCR and nested PCR to detect porcine hemagglutinating encephalomyelitis virus. J Vet Med Sci[J],2004,66(4):367-372.
[46]王世若,王兴龙,韩文瑜.现代动物免疫学[M].吉林：科学技术出版社,2001,418-419.
[47]Elia Q, Fiermonte, Pratelli A, et al. Recombinant M protein-based ELISA test for detection of antibodies to canine coronavirus [J]. J Virol Methods. 2003.109(2):139-142.
[48]李凌,马文丽.DNA芯片技术研究进展[J].中国生物化学与分子生物学报, 2000,16(2):151-155.
[49]石嵘,马文丽,刘翠华,等.两种限制性标记方法提高基因芯片杂交结果的信噪比[J].第一军医大学学报,2003,23(2)：124-126.
[50]Marra MA, Jones SJ, Astell CR, etal. The Genome Sequenee of the SARS assoeiated Coronavirus[J]..Seienee,2003,300(5624):1399-1404.
[51]张延龄,张辉.疫苗学[M].北京：科学出版社,2004：137-147.
[52]王明俊.兽医生物制品学[M].北京：中国农业出版社,1996：378-484.
[53]宁宜宝.兽用疫苗学[M].北京：中国农业出版社,2008：16-27.
[54]Yamanouchi K, Barret T, Kai C. New approaches to the development of virus vaccines for veterinary use[J]. Rev Sci Tech Off Int Epiz,1998(17):641-653.
[55]Pastoret P. Veterinary vaccinology[J]. C R Acad Sci,1999(322):967-972.
[56]夏咸柱,余春，黄耕,胡桂学,王允海,王长金.犬冠状病毒BEI灭活苗的制备与免疫试验[J].中国兽医杂志，2001，3(37)：37-38
[57]余春,夏咸柱,池元斌,张春红,黄耕,范泉水,何洪彬，王允海，刘海涛.犬冠状病毒压力灭活苗的制备与应用[J].研究中国兽医科技,2000,,5(30)：5-8
[58]William M A, Bobby E, John W B, et al. Canine Coronavirus Vaccine[A]. U nited States Patent.4567043,1986,1-28.
[59]马思奇,王明,周金法,等.猪流行性腹泻病毒适应Vero细胞及以传代细胞毒制备氢氧化铝灭活疫苗免疫效力试验[J].中国畜禽传染病,1994(2)：15-19.
[60]王俊东,蔡建平主编.畜禽群发性疾病防治[M].北京：中国农业出版社,2002,397-413
[61]Park. Eseors D, Ortego J, Enjuanes L. The membrane M Proteinear boxyter minalbinds to transmissible gastroenteritiseorona virus core and contributes to ceore stability[J]. J Virol,2001,75(3):1312-1324.
[62]童昆周,李力复,林志雄,等,猪流行性腹泻弱毒疫苗的研究[J].中国兽医科技,1996，26(1)：3-4.
[63]周仲方,冯力,李伟杰,等.猪传染性胃肠炎与猪流行性腹泻二联弱毒疫苗的研究[J].中国预防兽医学报,2002,21(6)：406-410.
[64]Edwards B G, Fulker R H. A cree W M. Evaluating a caninecoronavirus through antigen extinction and challenge studies[J]. Veterinary Medicine,1985,80 (28):30-33.
[65]Barry J. A corn-based delivery system for animal vaccines:an oral transmissible gastroenteritis virus vaccine boosts lacto genic immunity in swine[J].Vaccine. 2004,22:2420-2424.
[66]Siler CA,McGettigan JP, Dietzschold B, et al. Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines. Virology,2002.292: 24-34.
[67]Garwes D J, Lucas M H, Higgins D A. Antigenicity of structural components from porcine transmissible gastroenteritis virus[J].Vet Microbiol,1983,1:37-41.
[68]Godet M. Rasschaert D. Processing and antigenicity of entire and anchor-free spike glycoprotein S of coronavirus TGEV expressed by recombinant baculo virus[J]. Virology,1991,18(2):732-740.
[69]Shoup D I. Jackwood D J. Saif L J. Active and passive immune responses to transmissible gastroenteritis virus(TGEV) in swine inoculated with recombinant baculovirus-expressed TGEV.spike coprotein vaccines[J]. Am J Vet Res,1997,8(3):242-250.
[70]Tsuji M, Bergmann C C,Takita-Sonoda Y, et al. Recombinant sindbis viruses expressing a cytotoxic T lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice [J]. J Virol,1998,72:6907-6910.
[71]李忠明.当代新疫苗[M].北京：中国科学出版社，2003.48-78.
[72]Nakaya T. Cros J, Park MS, et al. Recombinant Newcastle disease virus as a vaccine vector. J. Virol.,2001.75:11868-11873
[73]Riffault, Pulfoul D J,Brittonp. Expression and cellular loealisation of poreine transmissible gastroenteritis virus N and MP roteins by recombinant vaccine viruses[J]. Virus Res,1991,18(2-3):203-217.
[74]Tamas. Plana Duran, Collins J E, Mengling W L. Efficacy of aninactived vaccine for Prevention of reproductive failure induced by porinere productive and respiration syndrome viru[J].Vet Microbiol,1997,55:361-370.
[75]Zakhartchouk, Godet M, Rasschaert D and anchor-free spike glycoprotein S Laude H. Processing and antigenicity of entire and of coronavirus SARS expressed by recombinant baculovirus[J]. Virology,1991.185(2):732-740.
[76]Tuboly T. Nagy E, Shinzato T. Immunogenicity of the Sprotein of transmissible gastroenteritis virus expressed in baculovirus[J].Arch Virol.1994,137:66-67.
[77]Song,Anton IM, Gonzalez S, Bullido MJ. Cooperation between IBV structural proteins in the in vitro induction of virus-specif c antibodies [J]. Virus Res.1996. 46(1-2):111-124.
[78]Wang X. Tomes JM, Sanchez C. Sune C. Induction of antibodies protecting against IBV by recombinant adenovirus expressing TGEV spike protein [J]. Virology,1995,213(2):5013-5016.
[79]Tuboly T and Nagy E. Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene [J]. J Gen Virol,2001,82(1):183-190.
[80]李琦涵.刘龙丁,车艳春.疫苗关键技术详解[M].北京，化学工业出版社,2006，41-51.
[81]Liu C, Kokuho T, Kubota T, et al. DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus [J]. Virus Res,2001,80(1-2):75-82.
[82]Annette Malene Barfoed. Fernando Rodriguez,Dominic Therrien et al. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/cmice. Antiviral Research,2006, (72):178-189.
[83]Riffault S, Baric R, Levyl. In vivo induction of inferonalpha in pig by non-infections coronavirus:tissue localization and in situ phenotypic characterization of inferonala producing cells[J]. Journal of General Virology,1997,78(10):2483-2487.
[84]Motokama K. Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, inteyral membrance and nucleocapsid protein of feline,canine and porcine coronavirus[J]. Microbiology and Immuunology,1996, 40(6):425-433.
[85]Tuboly T, Nagy E, Dennis J R, Derbyshire J B. Immunogenicity of the S protein of transmissible gastroenteritis virus expressed in baculo virus[J]. Arch Virol,1994,137:60-67.
[86]任晓峰,尹杰超,李一经,等.猪传染性胃肠炎病毒TH298株S基因核酸疫苗的构建及其免疫效力[J].中国兽医科学.2006，36(3)：203-206.
[87]Scott C, Weaver, Thomas W. Molecular evolution of eastern quine encephalomyelitis virus in North America[J].Virolog,1991,182(2):774-784.
[88]Gomez N. Carrillo C, Salinas J. Expression of Immunogenic Glycoprotein from Transmissible Gastroenteritis Coronavirusiy[J].Virology,2009,249(2):332-356.
[89]徐志凯.实用单克隆抗体技术[M].西安：陕西科学技术出版社,1991：125-126.
[90]张昶,任向阳,刘秋燕，等.单克隆抗体在畜禽疫病诊断中的应用.中国畜牧兽医,2007，34(5)：93-95
[91]许慧,倪安平.单克隆抗体及基因工程抗体在医学诊断上的应用.中华检验医学杂志,2005,28(6)：669-672
[92]沈关心，周汝麟.现代免疫学实验技术[M].第2版.武汉：湖北科学技术出版社,2001：32-37.
[93]朱立平,陈学清.免疫学常用实验方法[M].北京：人民军医出版社,2000.188-189
[94]Zhang Y,Rameshwer D S,Prem S P, et al.Monoclonal antibodies against conformationally dependent epitopes on porcine reproductive and respiratory syndrome [J].Veterinary microbiology,1998,73:125-136.
[95]徐志凯.实用单克隆抗体技术[M].西安：陕西科学技术出版社,1991：125-126.
[96]Milstein, Zhang YZ, Xiong CL, Zou Y, et al. Molecular characterization of rabies virus isolates in China during 2004. Virus Res.2006,121(2):79-88.
[97]Liddel J E, Cryer A. A practical guide to monoclonal antibodies[M]. Chichester: John Wiley, Sons Ltd,1991.
[98]Barski, Harty RN, Brown ME, et al. Rhabdoviruses and the cellular ubiquitin proteasome system:a budding interaction [J].J Virol.2001,75(22):10623-9.
[99]Okada, Harty RN, Paragas J, et al. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins:implications for viral budding [J]. J Virol.1999,73(4):2921-9
[100]高尚先,王玉琴,李修兰,等.大鼠抗-HBs的单克隆抗独特型抗体杂交瘤细胞系的建立[J].中国免疫学杂志，1993,9(2)：80-83.
[101]张昶,任向阳,刘秋燕,等.单克隆抗体在畜禽疫病诊断中的应用[J]..中国畜牧兽医,2007，34(5)：93-95.
[102]许慧,倪安平.单克隆抗体及基因工程抗体在医学诊断上的应用.中华检验医学杂志,2005，28(6)：669-672.
[103]Yang J. Koprowski H, Dietzschold B. et al. Phosphorylation of rabies virus nucleoprotein regulates viral RNA transcription and replication by modulating leader RNA encapsidation[J]. J Virol.1999,73(2):1661-1664.
[104]Mebatsion T, Weiland F, Conzelmann KK. Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G [J]. J Virol.1999,73(1):242-50.
[105]Heeschen C, Goldmann BU, Moeller RH, Hamm CW. Analytical performance and clinical application of a new rapid bedside assay for the detection of serum cardiac troponin I [J]. Clin Chem 1998.44:1925-1930.
[106]Laderman EI, Whitworth E. Dumaual E, et al. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood [J]. Clin Vaccine Immunol.2008,15:159-163.
[107]Zarakolu P, Buchanan I, Tam M, et al. Preliminary evaluation of an immunochromatographic strip test for specific Treponema pallidum antibodies [J]. J Clin Microbiol.2002.40:3064-3065.
[108]Grabar KC, Freeman RG. Hommer MB, et al. Preparation and characterization of Au colloid monolayers[J]. Anal Chem.1995,67:735-743.
[109]Arens MQ, Mundy LM, Amsterdam D, et al. Preclinical and clinical performance of the Efoora test, a rapid test for detection of human immunodeficiency virus-specific antibodies [J]. J Clin Microbiol.2005.43: 2399-2406.
[110]Biagini RE, Sammons DL, Smith JP, et al.:Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood[J]. Clin Vaccine Immunol. 2006,13:541-546.
[111]马红艳.胶体金诊断试剂盒中层析膜材料性能的分析.膜科学与技术.2002,22(6)：14-18.
[112]Viera AJ, Garrett JM. Understanding interobserver agreement:the kappa statistic[J]. Fam Med.2005,37:360-363.
[113]Dea S, Tijssen P. Detection of turkey enteric eoronavirus by enzyme linked immunosorbent assay and differentiation from other coronaviruses[J]. Am J Vet Res.1989.50:226-231.
[114]李永勤等.以膜为固体载体的免疫胶体金快速试验[M].微生物免疫学进展,2003,31(1).
[115]Bassab C, Syamal R. Manufacturing high quality gold sol[J]. IVD Technology 2001.8:46254.
[116]Chandler J,Gurmin T. The place of gold in rapid tests [J]. IVD Technology 2000,6:37249.
[117]Faulkh L, Taylor P. Fidanza N,etal. Single-step method forrap id detection of Brucella spp in soft cheese by gene-specific polymerase chain reaction[J]. J Dairy Res,1999,66(2):313-317
[118]Hermanson GT. Bioconjugate techniques[M]. Academic press,1996,593-602.
[119]Zhang GP, Guo JQ. Wang XN, et al.:Development and evaluation of an immunochromatographic strip for trichinellosis detection[J]. Vet Parasitol.2006, 137:286-293.
[120]Murphy FA. Paul J. Marian C. Veterinary Virology (Thirdedition)[M]. New York:Academic Press,1999.459-468.
[121]Henk L, Theresia H, Abdoel, Javier Solera, etal. Immunochromatographic Brucella-Specific Immunoglobulin Mand G Lateral Flow Assays for Rapid Sero diagnosis of Human Brucellosis[J]. Clinical and Diagnostic Laboratory,2003, 11:1141-1146
[122]Millipore, A short guide developing immunochromatographic test strips,2ed edition. Millipire Corparation, Bedford, MA,1999. p.2.
[123]Mildbrand, MM, Teramoto, YA, Collins, JK., et al.Rapid detection of canine parvovirus in feces using monoclonal antibodies and enzyme-linked immunosorbent assay [J]. Am J Vet Res.1984.45(11):2281-2284.
[124]Rimmelzwaan GF, Juntti N., et al. Evaluation of enzyme-linked immunosorbent assays based on monoclonal antibodies for the serology and antigen detection in canine parvovirus infections[J]. Vet Q.1990,12(1):14-20.
[125]何启强,杨进波,肖成峰,等.双抗夹心ELISA法检测血浆HSP70的建立及初步应用[J].环境与职业医学.2004,21(1)：24-26.
[126]吴保存,荆汝顶.确定ELISA试验阳性临界值的探讨[J].中国动物检疫,1994,11(5)：15-16.
[127]Cliquet F, McElhinney LM. Development of a qualitative indirect ELISA for the measurement of rabies virus-specific antibodies from vaccinated dogs and cats[J]. J Virol Methods.2003.117:1-8.
[128]Sato K, Inaia Y, Miura Y, Tokuhisa S, Matumoto M. Inducement of cytopathic changes and plaque for mation by porcine haemagglutinaling encephalomyelit virus[J]. Vet Microbiol.1983,8:521-530.
[129]Mengeling W, Coria MF. Buoyant density of hemagglutinating encephalomyelitis of swine:Comparison with avian bronchitis virus[J]. Am J Vet Res.1972,33:1359-1363.
[130]Hoorens J, Thoonen H, Gheyle M. Buyten A. Braakziekte bij biggen[J]. Vlaams Diergeneeskd Tijdschr[J].1977,46:209-224.
[131]Paul PS, Mengeling WI. Persistence of passivelyacquired antihodies to haemagglutinating encephalomyelifts virus in swine[J]. Am J Vet Res,1984,45: 932-934.
[132]Hirano N. Suzuki Y. Haga S. Pigs with highly prevalent antibodies to human coronavirus and swine haemagglutinating encephalomyelitis virus in the Tohoku District of Japan[J]. Epidemiol infect,1999,122:545-551.
[133]Hirano N, Nomura R, Tawara T,et al. Neurotropism of swine haemagglutinating encephalomyelitis virus (coronavirus) in mice depending upon host age and route of infection[J]. J Comp Pathol.2004,130(1):58-65.
[134]Hirano N, Tohyama K, Taira H. Spread of swine hemagglutinating encephalomyelitis virus from peripheral nerves to the CNS[J]. Adv Exp Med Biolo,1998,440:601-607.
[135]Sekiguchi Y, Shirai J. Taniguchi T, et al. Development of reverse transcriptase PCR and nested PCR to detect porcine hemagglutinating encephalomyelitis virus[J].J Vet Med Sci.2004,66(4):367-372.
[136]常灵竹,贺文琦,陆慧君.等.猪血凝性脑脊髓炎病毒RT-PCR方法的建立及初步应用[J].中国农学通报.200723(9)：15-18.
[137]耿百成,高丰,贺文琦.等.血凝性脑脊髓炎病毒血凝抑制试验方法的研究[J].动物医学进展.2005,26(6)：98-100.
[138]Oliver C. Conjugation of colloidal giold to proteins[J].Methods Mol Biol.1999, 115:331-334.
[139]Mena M L. Yanez-Sedeno P. Pingarron J M. A comparison of different strategies for the construction of amperometric enzyme biosensors using gold nanoparticle modified electrodes[J]. Anal Biochem.2005,336(1):20-27
[140]Tang D, Yuan R, Ch Y. etal. A novel immunosensor based on immobilization of hepatitis B surface antibody on platinum electrode modified colloidal gold and polyvinyl butyral as matrices via electrochemical impedance spectroscopy [J]. Bioelectrochemistry,2004,65(1):15-22.
[141]Yang J, Qunyi H, Huanchun,Jian L, Zhou. Development and evaluation of an immunochromatographic strip for the detection of serum antibodies against bluetongue virus[J]. Journal of Virological Methods.2010,163:68-73.
[142]Akaike Y, Miyahara T. SPF swine repopulation program. Japan SPF Swine Association edition, Chikusan Syuppan Co Tokyo. In:Pig Health Control. 1985.134-148.
[143]Trebeden H. Goffinet F. Kayem G. Maillard F, Lemoine E, Cabrol. D. Strip test for bedside detection of interleukin-6 in cervical secretions is predictive for impending preterm delivery[J]. Eur Cytokine Netw.2001.12:359.
[144]Kayem G, Goffinet F, Batteux F, Jarreau PH. Weill B. Detection of interleukin-6 in vaginal secretions of women with preterm premature rupture of membranes and its association with neonatal infection:a rapid immunochromatographic test[J]. Am J Obstet Gynecol.2005,192:140.
[145]Zhang GP, Guo JQ, Wang XN, Yang JX, Yang YY, Li QM, Li XW, Deng, RG. Development and evaluation of an immunochromatographic strip for trichinellosis detection[J]. Vet Parasitol.2006,137:286-293.
[146]Faulk WP, Taylor GM. An immunocolloid method for the electron microsco[J]. Immunochemistry.1997.8:1081-1083.
[147]Huang ZW. Zhu G. Szekeres H. Xia. Development of new rabbit monoclonal antibody to estrogen receptor:immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue section[J]. Appl Immunohistochem Mol Morphol.2005,13:91-95.
[148]Vaughn XL. Shi XE, Jin N, Xiong FH, Peng DP. Development and validation of an immunochromatographic assay for rapid detection of sulfadiazine in eggs and chickens[J]. J Chromatogr.2007,847:289-295.
[149]Yagami K, lzunli Y, Kajiwara N, Sugiyama F, Sugiyama Y. Neurotropism of mouse-adapted haemagglutinating encephalomyelitis virus[J]. J Comp Pathol. 1993.09:21-77.
[150]Schuhze B, Herrler G. Recognition of N acetyl-9-O-acetylneLlraminic acid by bovine coronavirus and hemagglutinating enceptlalonlyelitis Virus [J]. AdV Exp Med Bi0.1993,342:299-304.
[151]Sasseville AM, Boutin M, Gelinas AM, Dea S. Seauence of the 3*-terminal end(8.1 kb)of the genome of porcine haemagglutinating encephalomyelitis virus: Comparison with other haemagglutlnatlng coronavirus[J]. J Gen Virol.2002.83: 2411-2416.
[152]Appel M, Greig AS, Corner AH. Encephalomyelitis of swine caused by a haemagglutinating virus. Ⅳ[J]. Transmission studies Res Vet Sci.1965,6: 482-499.
[153]Hirano N, Ono K, Takasawa H, Murakami T, Haga S. Replication and plaque formation of swine haemagglutinating encephalomyelitis virus(67N)in swine cell line, SK-K culture[J]. J Virol Methods.1990.27:91-100.
[154]Sorensen KJ. Henlagglutinating encephalomyelit virus(HEV)infections in swine. Serologic indication for infectional occurrence in Denmark. Haemagglulinerende encephalomyelitis virus(HEV)infektioner hosgrise. Serologisk indikation for infektionens tilstedevaerelse i Denmark[J]. Nord Vet Med.1975,27:208-212.
[155]Vannier P, Chappuis G. Labadie JL. Renault L, Josse J. A serological survey of the virus of vomiting and wasting disease in piglets[J]. Ann Zootecb.1981,30: 379.
[156]Clements CJ and Griffiths E. The global impact of vaccines containing aluminium adjuvants[J]. Vaccine.2002,20 (Suppl.3):S24.
[157]Dong DX, Li QH. Foundation and application of vaccine technology [J]. Science Press. Peking of China.2002.149.
[158]HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants[J]. Vaccine.2002,20 (Suppl.3):S34.
[159]Prince GA, Denamur F. Deschamps M. Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease[J].Vaccine.2001,19 (15-16):2048.
[160]王大庆,于庆海,周园，等.现代免疫佐剂研究[J].中国免疫学杂志.2006.22 (2)：189-190.
[161]董德祥,李琦涵,褚嘉.疫苗技术基础与应用[M].北京：化学工业出版社,2002：149.
[162]Srivastava AK, Putnak, JR,Lee SH. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells[J]. Vaccine,200119 (31):45-57.
[163]陈光化.兽用新生物制品[J].中国禽业导刊.2002,19(14)：4-16.
[164]Nicklas W. Aluminum salts.Res Immunol[J].1992,143 (5):489-494.
[165]Clements CJ, Griffiths E. The global impact of vaccines containing aluminium adjuvants[J]. Vaccine.2002,20 (Suppl.3):S24.
[166]Dong DX, Li QH. Foundation and application of vaccine technology [J]. Science Press, Peking of China.2002,149.
[167]Weiss RC. Scott FW. Antibody-mediated enhancement of disease in feline infectious peritonitis:comparisons with dengue hemorrhagic fever[J]. Comp. Immunol. Microbiol. Infect. Dis.1981.4:175.
[168]Singh M, O'Hagan D. Advances in vaccine adjuvants[J]. Nat. Biotechnol.1999, 17:1075.
[169]Jordan MB, Mills DM, Kappler J, Marrack P. Cambier JC. Promotion of B cell immune responses via an aluminduced myeloid cell population[J]. Science.2004, 304:1808.
[170]Nicollier-Jamot B, Ogier A, Piroth L, Pothier P, Kohli E. Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in Balb/cmice induce specific humoral and cellular Thl/Th2-like immune responses[J]. Vaccine.2004, 22:1079.
[171]Bourgeois CH, Veiga-Fernandes AM, Joret B. Rocha C. Tanchot. CD 8 lethargy in the absence of CD 4 help[J]. Eur J Immunol.2002,32:2199-2207.
[172]Harty JT. Tvinnereim D W,White. CD 8+T cell effector mechanisms in resistance to infection[J]. Annu Rev Immunol.2000,18:275-308.
[173]Jordan MB, Mills DM, Kappler J. Marrack P. Cambier JC. Promotion of B cell immune responses via an aluminduced myeloid cell population[J]. Science. 2004,304:1808.
[174]Pope M, Chung SW, Mosmann T, Leibowitz JL. Gorczynski RM, Levy GA. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Thl. but not a Th2, response, whereas pre-existing antibody partially protects against primary infection[J]. J. Immunol.1996,156:3342.
[175]Wu CKJ. Rotte. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo[J]. Nat. Immunol.2002,3:852-831.
[176]Wu GF. Dandekar AA,Pewe L. Perlman S. The role of CD4 and CD8 T cells in MHV-JHM-induced demyelination[J]. Adv. Exp. Med. Biol.2001.494:341.
[177]Kelly E, Won Y. Refaeli L, Van Parijs. IL-2 and related cytokines can promote T cell survival by activating AKT 1[J]. J. Immunol.2002,168:597-603.
[178]Ren ZW. Li M. LLJP. The produce technology of SPF pig were application of modern raising pig in China[J]. Ani Sci and Med Sci.2001,18(4):56-58.